The Anxiolytic and Antidepressant Effects of Transcranial Magnetic Stimulation in Patients With Anxious Depression

被引:13
作者
Hutton, Todd M. [1 ]
Aaronson, Scott T. [2 ,3 ]
Carpenter, Linda L. [4 ,5 ]
Pages, Kenneth [6 ]
West, W. Scott [7 ]
Kraemer, Carlye [8 ]
Sackeim, Harold A. [9 ,10 ]
机构
[1] Southern Calif TMS Ctr, Los Angeles, CA USA
[2] Sheppard Pratt Hlth Syst, Baltimore, MD USA
[3] Univ Maryland, Dept Psychiat, Baltimore, MD USA
[4] Butler Hosp, Providence, RI USA
[5] Brown Univ, Dept Psychiat & Human Behav, Providence, RI USA
[6] TMS South Tampa, Tampa, FL USA
[7] Nashville NeuroCare Therapy, Nashville, TN USA
[8] NAMSA, St Louis Pk, MN USA
[9] Columbia Univ, Dept Psychiat, New York, NY USA
[10] Columbia Univ, Dept Radiol, New York, NY USA
关键词
GENERALIZED ANXIETY DISORDER; MAJOR DEPRESSION; NONANXIOUS DEPRESSION; TREATMENT OUTCOMES; CLINICAL-OUTCOMES; PREDICT RESPONSE; ELDERLY-PATIENTS; SCREENER GAD-7; OUTPATIENTS; PREVALENCE;
D O I
10.4088/JCP.22m14571
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: To determine the extent that treatment with transcranial magnetic stimulation (TMS) in diverse clinical settings has anxiolytic and antidepressant effects in patients with major depressive disorder (MDD) and moderate-to-severe anxiety symptoms and to contrast anxious and nonanxious depression subgroups in antidepressant effects. Methods: Within the NeuroStar Advanced Therapy System Clinical Outcomes Registry, 1,820 patients were identified with a diagnosis of MDD (using ICD-9, ICD-10, or DSM-IV) who completed the Patient Health Questionnaire-9 (PHQ-9) and Global Anxiety Disoder-7 scale (GAD-7) at baseline and following at least 1 TMS treatment between May 2016 and January 2021. Anxious depression was defined as a baseline GAD-7 score of 10 or greater (n = 1,514) and nonanxious depression by GAD-7 scores below this threshold (n = 306). Intent-to-treat and Completer samples were defined for patients treated with any TMS protocol and for the subgroup treated only with high-frequency left dorsolateral prefrontal cortex stimulation. Results: Patients with anxious depression showed clinically meaningful anxiolytic and antidepressant effects, averaging approximately 50% or greater reductions in both GAD-7 and PHQ-9 scores following TMS in all samples. The anxious and nonanxious depression groups had equivalent absolute improvement in PHQ-9 scores (P values >=.29). However, the anxious group had higher scores both at baseline and following TMS resulting in significantly lower categorical rates of response (P values <.02) and remission (P values <.001) in depressive symptoms. Among those with anxious depression, the change in anxiety and depression symptoms strongly covaried (r(1512) = 0.75, P <.001). Conclusions: Routine TMS delivered in diverse clinical settings results in marked anxiolytic and antidepressant effects in patients with anxious depression. The extent of improvement in anxiety and depression symptoms strongly covaries.
引用
收藏
页数:9
相关论文
共 58 条
[1]   Comparison of clinical outcomes with left unilateral and sequential bilateral Transcranial Magnetic Stimulation (TMS) treatment of major depressive disorder in a large patient registry [J].
Aaronson, Scott T. ;
Carpenter, Linda L. ;
Hutton, Todd M. ;
Kraus, Stacia ;
Mina, Miriam ;
Pages, Kenneth ;
Shi, Luoxi ;
West, W. Scott ;
Sackeim, Harold A. .
BRAIN STIMULATION, 2022, 15 (02) :326-336
[2]   Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression:: Replication study in drug-free patients [J].
Brakemeier, Eva-Lotta ;
Wilbertz, Gregor ;
Rodax, Silke ;
Danker-Hopfe, Heidi ;
Zinka, Bettina ;
Zwanzger, Peter ;
Grossheinrich, Nicola ;
Varkuti, Balint ;
Rupprecht, Rainer ;
Bajbouj, Malek ;
Padberg, Frank .
JOURNAL OF AFFECTIVE DISORDERS, 2008, 108 (1-2) :59-70
[3]   Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample [J].
Brown, TA ;
Campbell, LA ;
Lehman, CL ;
Grisham, JR ;
Mancill, RB .
JOURNAL OF ABNORMAL PSYCHOLOGY, 2001, 110 (04) :585-599
[4]   Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes A Systematic Review With Network Meta-analysis [J].
Brunoni, Andre R. ;
Chaimani, Anna ;
Moffa, Adriano H. ;
Razza, Lais B. ;
Gattaz, Wagner F. ;
Daskalakis, Zafiris J. ;
Carvalho, Andre F. .
JAMA PSYCHIATRY, 2017, 74 (02) :143-152
[5]   Comparison of clinical outcomes with two Transcranial Magnetic Stimulation treatment protocols for major depressive disorder [J].
Carpenter, Linda L. ;
Aaronson, Scott T. ;
Hutton, Todd M. ;
Mina, Miriam ;
Pages, Kenneth ;
Verdoliva, Sarah ;
West, W. Scott ;
Sackeim, Harold A. .
BRAIN STIMULATION, 2021, 14 (01) :173-180
[6]   TRANSCRANIAL MAGNETIC STIMULATION (TMS) FOR MAJOR DEPRESSION: A MULTISITE, NATURALISTIC, OBSERVATIONAL STUDY OF ACUTE TREATMENT OUTCOMES IN CLINICAL PRACTICE [J].
Carpenter, Linda L. ;
Janicak, Philip G. ;
Aaronson, Scott T. ;
Boyadjis, Terrence ;
Brock, David G. ;
Cook, Ian A. ;
Dunner, David L. ;
Lanocha, Karl ;
Solvason, H. Brent ;
Demitrack, Mark A. .
DEPRESSION AND ANXIETY, 2012, 29 (07) :587-596
[7]   Transcranial magnetic stimulation in anxiety and trauma-related disorders: A systematic review and meta-analysis [J].
Cirillo, Patricia ;
Gold, Alexandra K. ;
Nardi, Antonio E. ;
Ornelas, Ana C. ;
Nierenberg, Andrew A. ;
Camprodon, Joan ;
Kinrys, Gustavo .
BRAIN AND BEHAVIOR, 2019, 9 (06)
[8]   Efficacy of repetitive transcranial magnetic stimulation in the treatment of depression with comorbid anxiety disorders [J].
Clarke, Eleanor ;
Clarke, Patrick ;
Gill, Shane ;
Paterson, Tom ;
Hahn, Lisa ;
Galletly, Cherrie .
JOURNAL OF AFFECTIVE DISORDERS, 2019, 252 :435-439
[9]  
CLAYTON PJ, 1991, AM J PSYCHIAT, V148, P1512
[10]  
Cohen J, 1988, Statistical Power Analysis for the Behavioral Sciences A, V2nd, DOI DOI 10.4324/9780203771587